
Refocus Group Inc. Stock Analysis RFCS
Refocus Group, Inc. is a medical device company. The company is headquartered in Irving, Texas. The firm is involved in researching and developing treatments for human vision disorders, particularly for the treatment of presbyopia. The company is engaged in providing treatment for near vision correction. The Company’s product, VisAbility Micro Insert System, is a binocular presbyopic treatment that works outside the visual axis. VisAbility Micro Insert System is under clinical trials in the United States and aims to help patients reduce or eliminate their need for reading glasses.
Read More Refocus Group Inc (RFCS) Chart
Key Statistics of Refocus Group Inc (RFCS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.01Volume
-P/E Ratio (TTM)
-52 Week Range
Market Cap
25.00Avg. Volume
-Dividend Yield
-Financial Metrics & Statements of Refocus Group Inc (RFCS)
FAQ's for Refocus Group Inc (RFCS)
- According to Musaffa’s Shariah screening methodology, Refocus Group Inc (RFCS) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.